Bedimo Roger, Chen Ray Y, Accortt Neil A, Raper James L, Linn Carol, Allison Jeroan J, Dubay John, Saag Michael S, Hoesley Craig J
University of Alabama at Birmingham, USA.
Clin Infect Dis. 2004 Nov 1;39(9):1380-4. doi: 10.1086/424883. Epub 2004 Oct 11.
In a comparison of rates of acquired immunodeficiency syndrome (AIDS)-defining malignancies (ADMs) for 1989-1996 versus 1997-2002, we found a decrease in ADMs (rate ratio, 0.31; P<.0001) and a significant increase in non-AIDS-defining malignancies (non-ADMs; rate ratio, 10.87; P<.0002). The mean CD4 cell count was lower among patients with ADMs than among those with non-ADMs. A longer duration of survival during highly active antiretroviral therapy might explain the increasing incidence of non-ADMs.
在比较1989 - 1996年与1997 - 2002年获得性免疫缺陷综合征(AIDS)定义的恶性肿瘤(ADM)发生率时,我们发现ADM发生率下降(率比为0.31;P <.0001),而非AIDS定义的恶性肿瘤(非ADM)显著增加(率比为10.87;P <.0002)。ADM患者的平均CD4细胞计数低于非ADM患者。高效抗逆转录病毒治疗期间较长的生存时间可能解释了非ADM发病率的增加。